根据需要在轻度喘中使用阿尔布特罗尔-布德索尼德
Craig LaForce1, Frank Albers2, Anna Danilewicz3
1North Carolina Clinical Research, Raleigh.
The New England journal of medicine
|May 19, 2025
概括
根据需要使用的阿尔布特罗尔-布德索尼德,与单独使用阿尔布特罗尔相比,在轻度喘患者中显著降低了严重的喘恶化. 这种组合疗法为有效管理轻度喘提供了更安全的治疗选择.
科学领域:
- 肺部病理学 肺部病理学
- 临床药理学 临床药理学
- 喘管理 喘管理
背景情况:
- 在中度至重度喘中,按需要使用的阿尔布特罗尔-布德索尼德显示严重恶化风险低于单独使用阿尔布特罗尔.
- 关于在轻度喘中阿尔布特罗尔-布德索尼德疗效的数据有限.
研究的目的:
- 评估根据需要的阿尔布特罗尔-布德索尼德与阿尔布特罗尔在轻度喘患者的疗效和安全性.
- 为了确定对严重喘恶化和全身葡萄糖皮质激素暴露的影响.
主要方法:
- 一个虚拟的,分散的,双盲的,事件驱动的3b期试验.
- 2516名12岁以上的参与者患有轻度喘,SABA或低剂量吸入皮质类固醇/白三烯受体对抗剂无法控制.
- 随机 1:1 给需要的阿尔布特罗尔-布德索尼德 (180/160 微克) 或阿尔布特罗尔 (180 微克) 52 周.
主要成果:
- 为了有效性,该试验被提前停止.
- 在接受治疗 (5.1%对9.1%) 和有意治疗 (5.3%对9.4%) 的人群中,阿尔布特罗尔-布德索尼德显著减少了46-47%的严重喘恶化.
- 观察到每年恶化率较低 (0.15对0.32) 和全身葡萄糖皮质激素使用减少 (23.2对61.9毫克/年).
结论:
- 根据需要,阿尔布特罗尔-布德索尼德比单独的阿尔布特罗尔更有效地减少轻度,不受控制的喘中严重的喘恶化.
- 组合疗法表现出有利的安全性概况,在各组中出现类似的不良事件.
- 这项研究支持albuterol-budesonide作为轻度喘的有价值的治疗选择.
相关概念视频
Antiasthma Drugs: β2-Adrenoceptor Agonists
195
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
195
Asthma: Pathogenesis and Management
293
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
293
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
180
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
180
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
201
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
201
Inhaled Medications
210
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
210


